Related Experiment Videos
Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency
C Cunningham-Rundles1, Dennis L Cooper, Thomas P Duffy
1Department of Medicine, Mount Sinai School of Medicine, New York City, New York 10029, USA. charlotte.cunningham-rundles@mssm.edu
American Journal of Hematology
|March 14, 2002
Summary
Common variable immunodeficiency (CVID) increases non-Hodgkin's lymphoma (NHL) risk. This study identifies mucosa-associated lymphoid tissue (MALT) lymphomas in CVID patients, a novel finding in primary immunodeficiency.
Area of Science:
- Immunology
- Oncology
- Pathology
Background:
- Common variable immunodeficiency (CVID) is a primary immunodeficiency characterized by hypogammaglobulinemia and impaired B cell antibody production.
- Patients with CVID exhibit increased susceptibility to infections and a higher risk of developing non-Hodgkin's lymphoma (NHL), estimated between 1.4% and 7%.
Observation:
- A cohort study of 22 B cell lymphomas in CVID patients over 25 years revealed five cases of mucosa-associated lymphoid tissue (MALT) lymphomas.
- These MALT lymphomas arose in mucosal sites, a presentation not previously described in congenital immunodeficiency states.
Findings:
- The study identifies MALT lymphomas as a distinct entity within the spectrum of lymphomas associated with CVID.
- This finding suggests that chronic mucosal antigen stimulation, common in CVID, may contribute to the development of these specific B cell lymphomas.
Implications:
- This research highlights the importance of recognizing MALT lymphomas in CVID patients, potentially impacting diagnostic and treatment strategies.
- Further investigation into the mechanisms linking CVID, chronic inflammation, and MALT lymphoma development is warranted.